Gary Sender's Net Worth
$1.84 Million
Who is Gary Sender?
Gary Sender has an estimated net worth of $1.84 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Schrodinger, Inc., Harmony Biosciences Holdings, Inc., Nabriva Therapeutics AG, iBio, Inc., and Synergy Pharmaceuticals, Inc..
SEC CIK
Gary Sender's CIK is 0001659085
Past Insider Trading and Trends
2020 was Gary Sender's most active year for acquiring shares with 6 total transactions. Gary Sender's most active month to acquire stocks was the month of May. 2020 was Gary Sender's most active year for disposing of shares, totalling 14 transactions. Gary Sender's most active month to dispose stocks was the month of July. 2021 saw Gary Sender paying a total of $303,479.35 for 159,844 shares, this is the most they've acquired in one year. In 2021 Gary Sender cashed out on 57,618 shares for a total of $1,915,009.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nabriva Therapeutics Plc No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.2K |
—
|
—
| 2.2K |
Jun 23
| |||
| No matching records found | |||||||||
Schrodinger, Inc. (SDGR) Snapshot price: $20.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +80.00% | 5K |
—
|
—
| 11.25K |
Jun 18
| |||
Form 4
|
∞
| 6.25K |
—
|
—
| 6.25K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
$38.55 | -$1,611,358.78 |
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harmony Biosciences Holdings, Inc. (HRMY) Snapshot price: $35.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nabriva Therapeutics AG (NBRVF) Snapshot price: $0.000001
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.15% | -31.00 |
$2.39 | -$74.09 | 20.47K |
Feb 28
| |||
Form 4
| -0.18% | -37.00 |
$2.62 | -$96.94 | 20.5K |
Jan 31
| |||
Form 4
| -0.16% | -32.00 |
$2.42 | -$77.44 | 20.54K |
Dec 31
| |||
Form 4
| -0.15% | -312.00 |
$0.43 | -$133.22 | 205.73K |
Nov 30
| |||
Form 4
| -0.15% | -312.00 |
$0.50 | -$154.60 | 206.04K |
Oct 31
| |||
Form 4
| -0.15% | -312.00 |
$0.53 | -$166.30 | 206.35K |
Sep 30
| |||
Form 4
| -0.15% | -312.00 |
$0.62 | -$193.25 | 206.66K |
Aug 31
| |||
Form 4
| +4.04% | 8.05K |
$0.65 | -$2,074.91 | 206.98K |
Aug 19 - Aug 20
| |||
Form 4
| -0.16% | -312.00 |
$0.76 | -$237.12 | 198.93K |
Jul 31
| |||
Form 4
| -0.16% | -312.00 |
$0.67 | -$210.48 | 199.24K |
Jun 30
| |||
Form 4
| -0.16% | -312.00 |
$1.14 | -$355.68 | 199.55K |
May 31
| |||
Form 4
| -0.16% | -301.00 |
$0.55 | -$165.04 | 193.68K |
Apr 30
| |||
Form 4
| -0.15% | -301.00 |
$0.58 | -$173.07 | 193.98K |
Mar 31
| |||
Form 4
| -0.15% | -301.00 |
$1.35 | -$406.35 | 194.28K |
Feb 28
| |||
Form 4
| +133.47% | 105K |
—
|
—
| 183.67K |
Feb 6
| |||
Form 4
| -5.18% | -4.29K |
$1.35 | -$5,798.25 | 78.67K |
Jan 31
| |||
Form 4/A
| -15.00% | -3.39K |
$2.08 | -$7,051.20 | 19.21K |
Aug 21
| |||
Form 4
| +69.23% | 7.86K |
$2.08 | -$7,051.20 | 19.21K |
Aug 19 - Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +47.62% | 2K |
$4.57 | $9,140.00 | 6.2K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| +90.91% | 2K |
$8.21 | $16,420.00 | 4.2K |
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iBio, Inc. (IBIO) Snapshot price: $1.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||